Antifungal agents
US7863465B2 · kind B2 · utility
5Cited by
1References
38Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 29, 2007 |
| Grant date | Jan 4, 2011 |
| Priority date | — |
| Expiry date | Feb 19, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel enfumafungin derivatives of formula I and pharmaceutically acceptable salts thereof, their synthesis, and their use as inhibitors of (1,3)-β-D-glucan synthase. The present compounds and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising the present compounds and pharmaceutically acceptable salts thereof, are useful for treating or preventing antifungal infections and associated diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.